Product ID |
Product Name |
CAS# |
Purity |
Y3176094 |
4-Benzyloxy-3-ethylphenylboronic acid |
2137973-94-3 |
95% |
Y3311926 |
1-Bromo-2-chloro-3-(methylsulfanyl)benzene |
871352-88-4 |
95% |
Y3315245 |
1-(2-((3,4-Dimethylphenyl)thio)phenyl)piperazine hydrochloride |
1293342-97-8 |
95%+ |
Y3122430 |
t-Butyl4-(3-hydroxybenzoyl)piperazine-1-carboxylate |
219770-48-6 |
95% |
Y3122425 |
Methylthiazolo[5,4-b]pyridine-2-carboxylate |
1507491-46-4 |
95% |
Y3309260 |
9-(3-Bromo-5-chlorophenyl)-9H-carbazole |
1638533-94-4 |
95% |
Y3185110 |
Ethyl4-(5-fluoro-3-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
1809157-85-4 |
95% |
Y3176108 |
Ethyl2-bromo-3,6-difluorobenzoate |
1804408-94-3 |
95% |
Y3285940 |
Ethionamide-d3 |
2748267-66-3 |
95% |
Y3123218 |
Azithromycin-13C-d3 |
2750534-82-6 |
95% |
Y3123222 |
Enoxacin-d8 (hydrochloride) |
2930288-95-0 |
99.98% |
Y3288061 |
Cilastatin-15N-d3 |
2738376-83-3 |
99% |
Y3290107 |
Lenvatinib-d4 |
2264050-65-7 |
99% |
Y3123374 |
Ne-(1-Carboxymethyl)-L-lysine-d3 |
2699607-49-1 |
99% |
Y3294924 |
Tenofovir diphosphate (sodium salt) |
2738719-07-6 |
98% |
Y3294904 |
Decanoyl-L-carnitine-d3 (chloride) |
2483831-87-2 |
99% |
Y1343270 |
2-Methyl-4-(tetrahydro-2H-pyran-4-yl)pyridine 1-oxide |
865075-28-1 |
97% |
Y1235812 |
2-Cyclobutyl-10-methyl-3-phenylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione |
1613509-49-1 |
97% |
Y3139777 |
2-methoxy-4,4-dimethylpentanoic acid |
1557017-76-1 |
95% |
Y3139779 |
2-(2-methoxy-6-methylpyridin-4-yl)acetonitrile |
1227577-48-1 |
95% |
Y3139776 |
3-(dimethylamino)benzene-1-carbothioamide |
78950-35-3 |
95% |
Y3139792 |
3-(1H-imidazol-4-yl)benzonitrile |
88304-58-9 |
95% |
Y3139799 |
4-(2-hydroxyphenyl)pyrrolidin-2-one |
1367023-24-2 |
95% |
Y3139841 |
1-[(methylsulfanyl)methyl]cyclopropane-1-carboxylic acid |
1361150-25-5 |
95% |
Y3139815 |
2-(but-3-yn-1-yl)furan |
7051-47-0 |
95% |
Y3139848 |
tert-butyl N-[(1-ethynylcyclopropyl)methyl]carbamate |
2098039-92-8 |
95% |
Y3139850 |
2-methyl-4-(4-methylphenyl)butan-2-amine |
81561-38-8 |
95% |
Y1341643 |
(2R,4R)-4-Fluoro-2-methylpyrrolidineHCl |
2300174-87-0 |
98% |
Y3122562 |
4-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-2-methylbutanoic acid |
2229221-38-7 |
95% |
Y3176184 |
2-Chloro-1-(methoxymethoxy)-3(trifluoromethyl)benzene |
1820814-26-3 |
95% |
Y3122559 |
2-Chloro-2-ethoxycarbonyl-1-cyclopropanecarboxylicacid |
155687-17-5 |
95% |
Y1339841 |
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile |
1620575-06-5 |
97% |
Y3295605 |
Ethyl5-bromo-2-(trifluoromethyl)thiazole-4-carboxylate |
1639974-42-7 |
95% |
Y3290579 |
1-(2-Methyl-4-(trifluoromethyl)phenyl)ethan-1-one |
1600353-68-1 |
95% |
Y3113546 |
4-(prop-2-yn-1-yl)phenol |
39948-19-1 |
95% |
Y3123187 |
1-[(methylsulfanyl)methyl]cyclobutane-1-carboxylic acid |
1783500-49-1 |
95% |
Y3123156 |
5,6-Difluoropyridine-3-carbaldehyde |
1227583-68-7 |
95% |
Y3123174 |
tert-butyl 3-(2-hydroxy-2-methylpropyl)azetidine-1-carboxylate |
2228931-03-9 |
95% |
Y1344148 |
[4-(3-Chloro-4-fluorophenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]aceticacid |
1431953-77-3 |
95% |
Y3122534 |
2-Fluorobenzoyl fluoride |
13918-90-6 |
95% |
Y3317607 |
(4-chloro-3-(difluoromethoxy)phenyl)methanol |
1427447-85-5 |
95% |
Y3122535 |
3-Methylisoquinoline-8-carboxylicacid |
1416713-32-0 |
95% |
Y3173526 |
3-(Methoxycarbonyl)-5-(trifluoromethyl)phenylboronicacid |
1360771-83-0 |
95% |
Y3122540 |
4-(1-hydroxycyclopropyl)benzonitrile |
353283-29-1 |
95% |
Y3182382 |
tert-Butyl2-fluoro-5-iodobenzoate |
1382948-48-2 |
95% |
Y3311172 |
7-Methyl-imidazo[1,2-a]pyridine-3-carboxylicacidethylester |
1397228-36-2 |
98% |
Y3122888 |
[(2,5-Dimethyl-3-thienyl)methyl]methylaminehydrochloride |
1332531-27-7 |
95% |
Y3122890 |
2-(3-bromo-4-methoxyphenyl)-2-methylpropanoic acid |
93748-15-3 |
95% |
Y3122878 |
tert-butyl 2-(pyrrolidin-2-yl)piperidine-1-carboxylate |
1368135-28-7 |
95% |
Y3113259 |
3-Bromo-2-chloro-5-isopropylbenzoicacid |
2379321-70-5 |
95% |
Y3293773 |
Ethyl3-(1-fluorocyclopropyl)-3-oxopropanoate |
1877341-63-3 |
95% |
Y3311829 |
H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OHAcetate |
144027-77-0 |
97% |
Y3185227 |
Methyl4-cyclobutylbenzoate |
1378655-16-3 |
95% |
Y3179153 |
5-Amino-1-(4-methoxy-2-methyl-phenyl)-1H-pyrazole-4-carbonitrile |
1416344-73-4 |
97% |
Y3122474 |
rac4-Bocamino-2-isopropyl-butyricacidhydrochloride |
1387445-52-4 |
95% |
Y3113529 |
2-(Imidazol-1-yl)thiazole-4-boronicacidpinacolester |
1310404-67-1 |
95% |
Y3113523 |
Oxaliplatin-d10 |
1132819-16-9 |
95% |
Y3181874 |
2-Hydroxy-4’,5-diacetamido-diphenyl Ether |
2575516-61-7 |
99% |
Y3113517 |
3-(Aminomethyl)adamantan-1-olhydrochloride |
128487-54-7 |
95% |
Y3113522 |
5,5,5-Trifluoro-4-([((4-[(methoxycarbonyl)amino]phenyl)sulfonyl)amino]methyl)pentanoic acid |
300713-88-6 |
95% |
Y3287559 |
Acetic acid, 2-(1-phthalazinylthio)- |
314027-92-4 |
96% |
Y1240091 |
[(2-Methylprop-2-enyl)amino](2-pyridylamino)methane-1-thione |
141502-51-4 |
99% |
Y3113557 |
2-Methyl-1-oxo-1,2-dihydro-2,7-naphthyridine-4-carbaldehyde |
88752-78-7 |
95% |
Y3308238 |
Anhydronotoptol |
88206-51-3 |
98% |
Y3113534 |
2-chloro-N-[3-(propylthio)-1,2,4-thiadiazol-5-yl]acetamide |
302784-83-4 |
97% |
Y3286692 |
(2E)-N-(2-hydroxyphenyl)-3-phenylprop-2-enamide |
182572-98-1 |
95% |
Y3113726 |
1-(1,1-Dioxothiolan-3-yl)pyrazole-4-carboxylic acid |
1134714-88-7 |
95% |
Y3123225 |
4-Pyridin-2-yl-1,3-dihydro-1,5-benzodiazepin-2-one |
1023813-37-7 |
95% |
Y3179317 |
1-(pyridin-2-yl)-1H-pyrazole-4-sulfonyl chloride |
1097223-12-5 |
97% |
Y3295261 |
N-methoxy-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzoxepin-5-amine |
1410792-88-9 |
95% |
Y1244692 |
Methyl 2-(2-bromophenoxy)acetate |
787575-50-2 |
98% |
Y3123250 |
Ethyl 4-hydroxy-8-methoxy-6-methylquinoline-3-carboxylate |
1315343-70-4 |
95% |
Y3123258 |
4-Hydroxy-8-methoxy-6-methylquinoline-3-carboxylic acid |
1315373-21-7 |
95% |
Y3123280 |
(3-cyclopropyl-1H-1,2,4-triazol-5-yl)methanol |
1248451-67-3 |
95% |
Y1244682 |
Tert-butyl 2-(1-hydroxypropan-2-yl)hydrazinecarboxylate |
1785760-44-2 |
95% |
Y3123344 |
2-(3-(trifluoromethyl)-1H-pyrazol-4-yl)acetic acid |
1314923-82-4 |
95% |
Y3123350 |
Methyl 2-(1-adamantyl)-2-aminoacetate;hydrochloride |
95853-32-0 |
95% |
Y3293056 |
1-p-Tolyl-1h-pyrazole-4-carboxylic acid |
1053085-48-5 |
95% |
Y1240092 |
N-methyladamantane-1-carboxamide |
1501-97-9 |
99% |
Y3123354 |
1,1-Dimethylsilolane-3-carboxylic acid |
2109221-44-3 |
95% |
Y3123398 |
Ethyl 2-(benzyl(2-oxopropyl)amino)acetate |
15057-40-6 |
95% |
Y3297559 |
N,N'-dimethyl-p-xylylenediamine |
13093-02-2 |
95% |
Y1341748 |
Methyl 3-(4-ethoxyphenyl)-3-oxopropanoate |
294881-06-4 |
95% |
Y3123392 |
3-Methyl-4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid |
151051-63-7 |
90% |
Y3123421 |
2-[3-(Methoxycarbonyl)-5-methyl-1H-pyrazol-1-yl]acetic acid |
1211513-40-4 |
95% |
Y3130262 |
3-Azabicyclo[3.2.1]octan-1-amine;dihydrochloride |
2375272-92-5 |
95% |
Y3130263 |
2,5-Bis(prop-2-en-1-ylsulfanyl)-1,3,4-thiadiazole |
100377-90-0 |
95% |
Y3130271 |
2,2-Difluoro-2-(1-methylpyrazol-4-yl)sulfanylacetic acid |
1507854-27-4 |
95% |
Y1320098 |
1-[1-[(2-Methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]piperidine-4-carboxylic acid |
1259324-03-2 |
95% |
Y3130283 |
2-Cyclopropylimidazo[1,2-a]pyridine-6-carboxylic acid |
1343134-57-5 |
95% |
Y3130245 |
7-Bromo-2-hydroxynaphthalene-1-carbaldehyde |
1597710-22-9 |
95% |
Y3130256 |
2-Oxo-1-(thiolan-3-yl)pyridine-3-carboxylic acid |
2445786-34-3 |
95% |
Y3130284 |
2-(4-chlorophenyl)-4H-1,3,4-oxadiazin-5(6H)-one |
142048-60-0 |
95% |
Y3296356 |
ethyl 2-[(2-chloroacetyl)amino]-6-ethyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate;hydrochloride |
1027643-26-0 |
95% |
Y3130282 |
7-Chloro-5-methyl-3-phenylpyrazolo[1,5-a]pyrimidine |
58347-51-6 |
95% |
Y3130291 |
methyl 2-((5-(benzo[d][1,3]dioxol-5-yl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)acetate |
496776-13-7 |
95% |
Y1342819 |
Wnt/ß-catenin agonist 1 |
2305372-67-0 |
99% |
Y3122997 |
N-(2-methylpropyl)benzenesulfonamide |
23705-39-7 |
95% |
Y3310470 |
N-(3,4-dimethylphenyl)-2-(4-methylpiperazin-1-yl)pteridin-4-amine |
946289-84-5 |
95% |
Y3122920 |
4-chloro-N-[6-chloro-2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide |
374615-54-0 |
98% |